Advertisement
U.S. Markets close in 4 hrs 17 mins

Theriva Biologics Inc. R (SFY0.MU)

Munich - Munich Delayed Price. Currency in EUR
1.36000.0000 (0.00%)
As of 09:19AM CET. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
20,246
21,431
21,581
14,274
10,160
Operating Income
-20,246
-21,431
-21,581
-14,274
-10,160
Net Non Operating Interest Income Expense
1,096
1,439
512
6
44
Other Income Expense
-4,068
3
-41
-
-
Pretax Income
-23,218
-19,989
-21,110
-14,268
-10,116
Tax Provision
-951
-1,640
-1,425
0
-
Net Income Common Stockholders
-22,267
-18,349
-20,025
-23,189
-12,557
Diluted NI Available to Com Stockholders
-22,267
-18,349
-20,025
-23,189
-12,557
Basic EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Diluted EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Basic Average Shares
15,783
16,107
15,327
12,188
1,901
Diluted Average Shares
15,783
16,107
15,327
12,188
1,901
Total Operating Income as Reported
-24,314
-21,431
-21,581
-14,274
-10,160
Total Expenses
20,246
21,431
21,581
14,274
10,160
Net Income from Continuing & Discontinued Operation
-22,267
-18,349
-19,685
-14,267
-10,043
Normalized Income
-18,366
-18,352
-19,647
-14,267
-10,043
Interest Income
1,096
1,439
512
6
44
Net Interest Income
1,096
1,439
512
6
44
EBIT
-20,246
-21,431
-21,581
-14,274
-10,160
EBITDA
-20,098
-21,296
-21,496
-14,187
-9,959
Reconciled Depreciation
148
135
85
87
201
Net Income from Continuing Operation Net Minority Interest
-22,267
-18,349
-19,685
-14,267
-10,043
Total Unusual Items Excluding Goodwill
-4,068
3
-41
-
-
Total Unusual Items
-4,068
3
-41
-
-
Normalized EBITDA
-16,030
-21,299
-21,455
-14,187
-9,959
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-166.6237
0.246
-2.7675
0
0